Enforcement: Feds Double Down Scrutiny of COVID Fraud

Subscribe or sign in to view the full article.

Note:  The following article synopsis was NOT provided by AAPC. It was created by Find-A-Code/innoviHealth.

Article Overview

This article summarizes a recent HHS Office of Inspector General semiannual report and highlights how federal enforcement priorities have centered on COVID-19-related fraud and abuse. It is relevant to compliance teams, auditors, coders, billing staff, and healthcare leaders who track fraud enforcement activity affecting Medicare and other federal healthcare programs. The article also reviews several high-profile Medicare fraud cases involving home health, durable medical equipment, and laboratory testing/telemedicine-related schemes, along with broad enforcement statistics and recovery figures.

Why This Topic Matters

The article helps readers understand current enforcement focus areas that may affect compliance monitoring, billing oversight, and fraud risk assessment in healthcare organizations participating in federal programs.

Article Sections

  1. Background

    Introduces the OIG semiannual reporting framework and explains the broad enforcement focus during the reporting period, with emphasis on COVID-19 response and recovery efforts.

  2. Statistics

    Summarizes the report’s enforcement and recovery totals, including audits, evaluations, investigations, criminal and civil actions, and exclusions.

  3. Critical

    Describes the report’s Medicare-related concerns tied to COVID-19 testing trends and broader laboratory spending patterns.

  4. Check Out These Top Medicare Enforcement Cases

    Introduces a set of notable Medicare fraud matters highlighted in the report, spanning multiple areas of alleged misconduct.

  5. Home health

    Covers a major home health fraud case referenced in the report, including the enforcement outcome and related fugitive history.

  6. DME

    Reviews a durable medical equipment fraud case involving Medicare claims, financial losses, and criminal sentencing.

  7. Lab testing

    Summarizes a laboratory testing and telemedicine-related Medicare fraud scheme discussed in the report.

What You Will Learn

  • How the OIG framed its enforcement priorities during the reporting period
  • What types of healthcare fraud cases were emphasized in the report
  • How the article characterizes COVID-19’s role in federal fraud scrutiny
  • Which broad categories of Medicare-related schemes were highlighted
  • What enforcement and recovery activity the OIG reported during the period

Who Should Read This

  • Healthcare compliance professionals
  • Medical billing and coding staff
  • Revenue cycle teams
  • Healthcare auditors
  • Practice administrators
  • Hospital and health system leaders
  • Fraud and abuse investigators

Subscribe or sign in to view the full article.

Keep pace with evolving Medicare regulations — and onboard your team — with timely analysis of critical updates interpreted in an easy-to-follow, easy-to-apply format. Your subscription to TCI's Medicare Compliance & Reimbursement Alert will equip you to navigate code and guideline changes, CCI edits, and revisions to modifiers, payer policies, the fee schedule, OIG target areas, and more.

  • Current newsletters added each month
  • Fully searchable archives - over 4200 articles
  • ALL years/issues back to 2003 organized by year and issue
  • Codes mentioned in articles are linked to Code Information pages
  • Code Information pages link back to related articles

This feature is currently unavailable for online purchase. For more information, please call 801-770-4203 or Contact Us.

Thank you for choosing Find-A-Code, please Sign In to remove ads.

Aimee- AI -powered coding assistant - Try it now for Free Would you like Aimee - AI
to help you with this?